Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 1
2003 1
2004 2
2005 2
2006 2
2007 1
2008 1
2009 1
2011 1
2012 2
2013 4
2014 3
2015 3
2016 4
2018 1
2019 1
2020 1
2021 5
2022 4
2023 6
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

40 results

Results by year

Filters applied: . Clear all
Page 1
Spatial characterisation of β-catenin-mutated hepatocellular adenoma subtypes by proteomic profiling of the tumour rim.
Di Tommaso S, Dourthe C, Dupuy JW, Dugot-Senant N, Cappellen D, Cazier H, Paradis V, Blanc JF, Le Bail B, Balabaud C, Bioulac-Sage P, Saltel F, Raymond AA. Di Tommaso S, et al. Among authors: cappellen d. JHEP Rep. 2023 Sep 22;6(2):100913. doi: 10.1016/j.jhepr.2023.100913. eCollection 2024 Feb. JHEP Rep. 2023. PMID: 38304236 Free PMC article.
New 2,4-bis[(substituted-aminomethyl)phenyl]phenylquinazoline and 2,4-bis[(substituted-aminomethyl)phenyl]phenylquinoline Derivatives: Synthesis and Biological Evaluation as Novel Anticancer Agents by Targeting G-Quadruplex.
Guillon J, Le Borgne M, Milano V, Guédin-Beaurepaire A, Moreau S, Pinaud N, Ronga L, Savrimoutou S, Albenque-Rubio S, Marchivie M, Kalout H, Walker C, Chevallier L, Buré C, Largy E, Gabelica V, Mergny JL, Baylot V, Ferrer J, Idrissi Y, Chevret E, Cappellen D, Desplat V, Schelz Z, Zupkó I. Guillon J, et al. Among authors: cappellen d. Pharmaceuticals (Basel). 2023 Dec 25;17(1):30. doi: 10.3390/ph17010030. Pharmaceuticals (Basel). 2023. PMID: 38256866 Free PMC article.
Spotlight on hTERT Complex Regulation in Cutaneous T-Cell Lymphomas.
Ropio J, Prochazkova-Carlotti M, Batista R, Pestana A, Chebly A, Ferrer J, Idrissi Y, Cappellen D, Durães C, Boaventura P, Vinagre J, Azzi-Martin L, Poglio S, Cabeçadas J, Campos MA, Beylot-Barry M, Sobrinho-Simões M, Merlio JP, Soares P, Chevret E. Ropio J, et al. Among authors: cappellen d. Genes (Basel). 2023 Feb 8;14(2):439. doi: 10.3390/genes14020439. Genes (Basel). 2023. PMID: 36833366 Free PMC article.
FACILITATE: A real-world, multicenter, prospective study investigating the utility of a rapid, fully automated real-time PCR assay versus local reference methods for detecting epidermal growth factor receptor variants in NSCLC.
Behnke A, Cayre A, De Maglio G, Giannini G, Habran L, Tarsitano M, Chetta M, Cappellen D, Lespagnol A, Le Naoures C, Massazza G, Destro A, Bonzheim I, Rau A, Battmann A, Kah B, Watkin E, Hummel M. Behnke A, et al. Among authors: cappellen d. Pathol Oncol Res. 2023 Jan 31;29:1610707. doi: 10.3389/pore.2023.1610707. eCollection 2023. Pathol Oncol Res. 2023. PMID: 36798672 Free PMC article.
Cutaneous Lymphocyte Antigen Is a Potential Therapeutic Target in Cutaneous T-Cell Lymphoma.
Peru S, Prochazkova-Carlotti M, Cherrier F, Velazquez J, Richard E, Idrissi Y, Cappellen D, Azzi-Martin L, Pham-Ledard A, Beylot-Barry M, Merlio JP, Poglio S. Peru S, et al. Among authors: cappellen d. J Invest Dermatol. 2022 Dec;142(12):3243-3252.e10. doi: 10.1016/j.jid.2022.06.016. Epub 2022 Jul 16. J Invest Dermatol. 2022. PMID: 35850209 Free article.
An EZH2 blocker sensitizes histone mutated diffuse midline glioma to cholesterol metabolism inhibitors through an off-target effect.
Rahal F, Capdevielle C, Rousseau B, Izotte J, Dupuy JW, Cappellen D, Chotard G, Ménard M, Charpentier J, Jecko V, Caumont C, Gimbert E, Grosset CF, Hagedorn M. Rahal F, et al. Among authors: cappellen d. Neurooncol Adv. 2022 Mar 1;4(1):vdac018. doi: 10.1093/noajnl/vdac018. eCollection 2022 Jan-Dec. Neurooncol Adv. 2022. PMID: 35300150 Free PMC article.
Positive Association Between Location of Melanoma, Ultraviolet Signature, Tumor Mutational Burden, and Response to Anti-PD-1 Therapy.
Dousset L, Poizeau F, Robert C, Mansard S, Mortier L, Caumont C, Routier É, Dupuy A, Rouanet J, Battistella M, Greliak A, Cappellen D, Galibert MD, Allayous C, Lespagnol A, Gerard É, Kerneuzet I, Roy S, Dutriaux C, Merlio JP, Vergier B, Schrock AB, Lee J, Ali SM, Kammerer-Jacquet SF, Lebbé C, Beylot-Barry M, Boussemart L. Dousset L, et al. Among authors: cappellen d. JCO Precis Oncol. 2021 Dec 16;5:PO.21.00084. doi: 10.1200/PO.21.00084. eCollection 2021. JCO Precis Oncol. 2021. PMID: 34950838 Free PMC article.
40 results